Immuneering CorporationIMRXNASDAQ
Loading
Cost of Revenue Over TimeStable
Percentile Rank50
3Y CAGR+64.1%
5Y CAGR-11.4%
Year-over-Year Change
Direct costs attributable to producing goods sold
3Y CAGR
+64.1%/yr
Annual compound
5Y CAGR
-11.4%/yr
Recent acceleration
Percentile
P50
Within normal range
vs 5Y Ago
0.5x
Contraction
Streak
1 yr
Consecutive growthStable
| Period | Value | YoY Change |
|---|---|---|
| TTM | $698887.00 | - |
| 2024 | $0.00 | - |
| 2023 | $0.00 | -100.0% |
| 2022 | $158122.00 | -86.3% |
| 2021 | $1.15M | -9.9% |
| 2020 | $1.28M | +4.7% |
| 2019 | $1.22M | - |